Inhibition of Sirt1 was shown to sensitize cells for DNA-damaging cancer therapeutics [24], and inhibition of Sirt1 and Sirt2 can itself decrease tumor growth [25, 26]. The gene discussed is SIRT2; the disease is neoplasm.